• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在v-ErbA中缺失的保守C末端序列对c-ErbA(甲状腺激素受体)的生物学活性至关重要。

A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).

作者信息

Saatcioglu F, Bartunek P, Deng T, Zenke M, Karin M

机构信息

Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla 92093-0636.

出版信息

Mol Cell Biol. 1993 Jun;13(6):3675-85. doi: 10.1128/mcb.13.6.3675-3685.1993.

DOI:10.1128/mcb.13.6.3675-3685.1993
PMID:8098843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC359836/
Abstract

The thyroid hormone (T3) receptor type alpha, the c-ErbA alpha proto-oncoprotein, stimulates transcription of T3-dependent promoters, interferes with AP-1 activity, and induces erythroid differentiation in a ligand-dependent manner. The v-ErbA oncoprotein does not bind hormone and has lost all of these activities. Using c-ErbA/v-ErbA chimeras, we found that a deletion of 9 amino acids, conserved among many members of the nuclear receptor superfamily, which are located at the extreme carboxy terminus of c-ErbA alpha is responsible for loss of both transactivation and transcriptional interference activities. Single, double, and triple amino acid substitutions within this region completely abolished T3-dependent transcriptional activation, interference with AP-1 activity, and decreased T3 binding by c-ErbA alpha. However, the lower T3 binding by these mutants does not fully account for the loss of transactivation and transcriptional interference, since a c-ErbA/v-ErbA chimera which was similarly reduced in T3 binding activity has retained both of these functions. Deletion of homologous residues in the retinoic acid receptor alpha (RAR alpha) resulted in a similar loss of transactivation and transcriptional interference activities. The ability of c-ErbA alpha to induce differentiation of transformed erythroblasts is also impaired by all of the mutations introduced into the conserved carboxy-terminal sequence. We conclude that this 9-amino-acid conserved region is essential for normal biological function of c-ErbA alpha and RAR alpha and possibly other T3 and RA receptors.

摘要

甲状腺激素(T3)α型受体,即c-ErbAα原癌蛋白,可刺激T3依赖性启动子的转录,干扰AP-1活性,并以配体依赖性方式诱导红细胞分化。v-ErbA癌蛋白不结合激素,且已丧失所有这些活性。利用c-ErbA/v-ErbA嵌合体,我们发现位于c-ErbAα极端羧基末端的一段9个氨基酸的缺失,该缺失在核受体超家族的许多成员中保守,是导致反式激活和转录干扰活性丧失的原因。该区域内的单个、双个和三个氨基酸取代完全消除了T3依赖性转录激活、对AP-1活性的干扰,并降低了c-ErbAα与T3的结合。然而,这些突变体与T3较低的结合并不能完全解释反式激活和转录干扰的丧失,因为一个T3结合活性同样降低的c-ErbA/v-ErbA嵌合体保留了这两种功能。视黄酸受体α(RARα)中同源残基的缺失导致了类似的反式激活和转录干扰活性丧失。引入保守羧基末端序列的所有突变也损害了c-ErbAα诱导转化成红细胞分化的能力。我们得出结论,这个9个氨基酸的保守区域对于c-ErbAα和RARα以及可能其他T3和视黄酸受体的正常生物学功能至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27a/359836/8f8a3a25dc79/molcellb00018-0569-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27a/359836/a5b4ae511d6d/molcellb00018-0569-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27a/359836/8f8a3a25dc79/molcellb00018-0569-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27a/359836/a5b4ae511d6d/molcellb00018-0569-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27a/359836/8f8a3a25dc79/molcellb00018-0569-b.jpg

相似文献

1
A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).在v-ErbA中缺失的保守C末端序列对c-ErbA(甲状腺激素受体)的生物学活性至关重要。
Mol Cell Biol. 1993 Jun;13(6):3675-85. doi: 10.1128/mcb.13.6.3675-3685.1993.
2
Role of the conserved C-terminal region of thyroid hormone receptor-alpha in ligand-dependent transcriptional activation.甲状腺激素受体α保守C末端区域在配体依赖性转录激活中的作用。
Mol Cell Endocrinol. 1998 Mar 16;138(1-2):105-14. doi: 10.1016/s0303-7207(98)00016-1.
3
Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.甲状腺激素受体保守C末端序列中的突变使激素依赖性激活与对AP-1活性的干扰相分离。
Mol Cell Biol. 1997 Aug;17(8):4687-95. doi: 10.1128/MCB.17.8.4687.
4
Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.Myb-Ets融合癌蛋白抑制甲状腺激素受体/c-ErbA和视黄酸受体功能:E26禽逆转录病毒致白血病转化的一种新作用机制。
Mol Cell Biol. 1996 Nov;16(11):6338-51. doi: 10.1128/MCB.16.11.6338.
5
Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
J Biol Chem. 1991 Jun 25;266(18):11589-93.
6
Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.内源性甲状腺激素和视黄酸受体对正常红系分化的调节:v-erbA癌基因作用的一个可能靶点。
Oncogene. 1992 Feb;7(2):217-27.
7
v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
Cell. 1990 Jun 15;61(6):1035-49. doi: 10.1016/0092-8674(90)90068-p.
8
Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.甲状腺激素受体的转录活性可能受到该受体截短形式的自身调节。
Mol Cell Biol. 1992 May;12(5):2406-17. doi: 10.1128/mcb.12.5.2406-2417.1992.
9
v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.
Genes Dev. 1991 Nov;5(11):2033-47. doi: 10.1101/gad.5.11.2033.
10
A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.可转移的沉默结构域存在于甲状腺激素受体、v-erbA癌基因产物和视黄酸受体中。
EMBO J. 1992 Mar;11(3):1015-23. doi: 10.1002/j.1460-2075.1992.tb05140.x.

引用本文的文献

1
Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature.甲状腺激素信号通路:是时候采用更精确的命名法了。
Endocrinology. 2017 Jul 1;158(7):2052-2057. doi: 10.1210/en.2017-00250.
2
The vitamin D(3) receptor in the context of the nuclear receptor superfamily : The central role of the retinoid X receptor.核受体超家族背景下的维生素D(3)受体:视黄酸X受体的核心作用。
Endocrine. 1996 Apr;4(2):91-105. doi: 10.1007/BF02782754.
3
Designer monotransregulators provide a basis for a transcriptional therapy for de novo endocrine-resistant breast cancer.

本文引用的文献

1
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.在哺乳动物细胞中表达氯霉素乙酰转移酶的重组基因组。
Mol Cell Biol. 1982 Sep;2(9):1044-51. doi: 10.1128/mcb.2.9.1044-1051.1982.
2
Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation.禽成红细胞增多症病毒的v-erbA和v-erbB癌基因在红细胞转化中的作用。
Cell. 1983 Aug;34(1):7-9. doi: 10.1016/0092-8674(83)90130-7.
3
Erythroblast cell lines transformed by a temperature-sensitive mutant of avian erythroblastosis virus: a model system to study erythroid differentiation in vitro.
设计的单转录调节剂为从头发生内分泌抵抗的乳腺癌的转录治疗提供了基础。
Mol Med. 2010 Jan-Feb;16(1-2):10-8. doi: 10.2119/molmed.2009.00107. Epub 2009 Nov 17.
4
Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones.在介导佛波酯和激素调控的胶原酶-3反应元件处的因子募集及TIF2/GRIP1共抑制因子活性。
EMBO J. 2001 Nov 1;20(21):6071-83. doi: 10.1093/emboj/20.21.6071.
5
Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway.癌蛋白v-erbA对N-CoR和组蛋白去乙酰化酶3的靶向作用产生了一种依赖染色质结构的转录抑制途径。
EMBO J. 2000 Aug 1;19(15):4074-90. doi: 10.1093/emboj/19.15.4074.
6
Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors.特定的结构基序决定TRAP220与核激素受体的相互作用。
Mol Cell Biol. 2000 Aug;20(15):5433-46. doi: 10.1128/MCB.20.15.5433-5446.2000.
7
Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.v-ErbA癌蛋白导致的白血病转化在体内需要与红系增强子持续结合并对其进行抑制。
EMBO J. 1998 Dec 15;17(24):7382-94. doi: 10.1093/emboj/17.24.7382.
8
The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.甲状腺激素受体作为红系祖细胞增殖与分化之间的配体调控发育开关发挥作用。
EMBO J. 1998 Aug 3;17(15):4291-303. doi: 10.1093/emboj/17.15.4291.
9
Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor.类固醇受体共激活因子1的亚型在增强雌激素受体转录的能力上存在差异。
EMBO J. 1998 Jan 2;17(1):232-43. doi: 10.1093/emboj/17.1.232.
10
Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway.通过抑制JNK途径实现核激素受体与AP-1的拮抗作用。
Genes Dev. 1997 Dec 15;11(24):3351-64. doi: 10.1101/gad.11.24.3351.
由禽成红细胞增多症病毒温度敏感突变体转化的成红细胞系:体外研究红细胞分化的模型系统。
J Cell Physiol Suppl. 1982;1:195-207. doi: 10.1002/jcp.1041130427.
4
The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements.甲状腺激素受体与甲状腺激素和雌激素反应元件中的一个共同序列基序结合,产生相反的转录效应。
Cell. 1988 Jul 29;54(3):313-23. doi: 10.1016/0092-8674(88)90194-8.
5
Temperature-sensitive v-sea transformed erythroblasts: a model system to study gene expression during erythroid differentiation.温度敏感型v-sea转化的成红细胞:一种研究红细胞分化过程中基因表达的模型系统。
Genes Dev. 1988 Feb;2(2):247-58. doi: 10.1101/gad.2.2.247.
6
Characterization of the hormone-binding domain of the chicken c-erbA/thyroid hormone receptor protein.鸡c-erbA/甲状腺激素受体蛋白激素结合结构域的特性分析
EMBO J. 1988 Jan;7(1):155-9. doi: 10.1002/j.1460-2075.1988.tb02795.x.
7
A versatile in vivo and in vitro eukaryotic expression vector for protein engineering.一种用于蛋白质工程的多功能体内和体外真核表达载体。
Nucleic Acids Res. 1988 Jan 11;16(1):369. doi: 10.1093/nar/16.1.369.
8
The steroid and thyroid hormone receptor superfamily.类固醇和甲状腺激素受体超家族。
Science. 1988 May 13;240(4854):889-95. doi: 10.1126/science.3283939.
9
The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes.c-Fos蛋白与c-Jun/AP-1相互作用,以刺激AP-1反应基因的转录。
Cell. 1988 Aug 12;54(4):541-52. doi: 10.1016/0092-8674(88)90076-1.
10
Fos-associated protein p39 is the product of the jun proto-oncogene.Fos相关蛋白p39是原癌基因jun的产物。
Science. 1988 May 20;240(4855):1010-6. doi: 10.1126/science.3130660.